Simplex Trading’s CureVac CVAC Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q4 | – | Sell |
-14,903
| Closed | -$76.3K | – | 8817 |
|
|
2025
Q3 | $80K | Sell |
14,903
-7,592
| -34% | -$41.1K | ﹤0.01% | 5996 |
|
|
2025
Q2 | $122K | Buy |
22,495
+9,019
| +67% | +$35.8K | ﹤0.01% | 5037 |
|
|
2025
Q1 | $37K | Buy |
13,476
+6,076
| +82% | +$21.1K | ﹤0.01% | 6067 |
|
|
2024
Q4 | $25K | Buy |
7,400
+3,038
| +70% | +$8.76K | ﹤0.01% | 6494 |
|
|
2024
Q3 | $12K | Sell |
4,362
-29
| -0.7% | -$96 | ﹤0.01% | 7056 |
|
|
2024
Q2 | $14K | Buy |
4,391
+2,398
| +120% | +$7.84K | ﹤0.01% | 7172 |
|
|
2024
Q1 | $6K | Buy |
+1,993
| New | +$7K | ﹤0.01% | 7899 |
|
|
2023
Q4 | – | Sell |
-11,192
| Closed | -$60.7K | – | 8942 |
|
|
2023
Q3 | $76K | Sell |
11,192
-7,426
| -40% | -$65.6K | ﹤0.01% | 5378 |
|
|
2023
Q2 | $193K | Buy |
18,618
+13,543
| +267% | +$121K | ﹤0.01% | 4328 |
|
|
2023
Q1 | $35K | Sell |
5,075
-14,847
| -75% | -$129K | ﹤0.01% | 6322 |
|
|
2022
Q4 | $120K | Buy |
+19,922
| New | +$147K | ﹤0.01% | 4850 |
|
|
2022
Q2 | – | Sell |
-19,972
| Closed | -$330K | – | 10117 |
|
|
2022
Q1 | $391K | Buy |
19,972
+11,040
| +124% | +$220K | ﹤0.01% | 4179 |
|
|
2021
Q4 | $306K | Buy |
8,932
+8,266
| +1,241% | +$333K | ﹤0.01% | 4532 |
|
|
2021
Q3 | $45K | Buy |
+666
| New | +$40.1K | ﹤0.01% | 7620 |
|
|
2021
Q1 | – | Sell |
-181
| Closed | -$17.6K | – | 8997 |
|
|
2020
Q4 | $0 | Buy |
+181
| New | +$13.9K | ﹤0.01% | 8442 |
|
Simplex Trading's CVAC Position: Q4 2025 in Review
Simplex Trading sold out of CureVac (CVAC) in Q4 2025, closing a stake of 14,903 shares — an estimated $76.3K sold.
Simplex Trading first reported a position in CVAC in Q4 2020 and held it in 15 quarters. The position peaked at $391K in Q1 2022. 57 funds tracked by Wall St. Rank hold CVAC as of Q4 2025.
- Simplex Trading reported no remaining CureVac position as of Q4 2025 after selling out during the quarter.
- Simplex Trading sold 14,903 CureVac shares in Q4 2025, an estimated $76.3K.
- Simplex Trading first reported a position in CureVac in Q4 2020 and held it in 15 quarters.
- Simplex Trading's CureVac position peaked at $391K in Q1 2022.
- 57 funds tracked by Wall St. Rank held CureVac as of Q4 2025.
Based on Simplex Trading's 13F filing for Q4 2025, filed 11 Feb 2026.